These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 658877)

  • 1. [Effect of naproxen on the thrombocyte bleeding time and on the anticoagulant treatment with phenprocoumon].
    Angelkort B
    Fortschr Med; 1978 Jun; 96(23):1249-52. PubMed ID: 658877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of daily administration of naproxen on the prothrombin complex activity in patients under long-term therapy with phenprocoumon.
    Petersen PB; Husted S; Mortensen A; Andreasen F
    Scand J Rheumatol; 1979; 8(1):54-6. PubMed ID: 311940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of fibrinopeptide A in patients treated with phenprocoumon.
    Harenberg J; Haas R; Zimmermann R
    Thromb Haemost; 1981 Jun; 45(3):282-4. PubMed ID: 7281107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The concomitant use of suloctidil and a long-acting oral anticoagulant.
    Verhaeghe R; Vanhoof A
    Acta Clin Belg; 1977; 32(1):36-8. PubMed ID: 331824
    [No Abstract]   [Full Text] [Related]  

  • 5. On the interaction between the anti-inflammatory substance proquazone (RU 43-715) and phenprocoumone.
    Vinazzer H
    Int J Clin Pharmacol Biopharm; 1977 May; 15(5):214-6. PubMed ID: 326688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of allopurinol with phenprocoumon in man.
    Jähnchen E; Meinertz I; Gilfrich HJ
    Klin Wochenschr; 1977 Aug; 55(15):759-61. PubMed ID: 895010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Behavior of serum triglycerides, cholesterol, uric acid and sugar levels and of thrombocyte function in heart infarct patients during a 2-year therapy with acetylsalicylic acid, placebo or phenprocoumon].
    Weber E; Walter E; Pfleiderer T
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1731-5. PubMed ID: 347797
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognosis in patients with cerebral ischemia treated with short term anticoagulant therapy -- a controlled trial (author's transl)].
    Gallhofer B; Ladurner G; Lechner H
    Fortschr Neurol Psychiatr Grenzgeb; 1980 Aug; 48(8):409-14. PubMed ID: 6902691
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of BM 15075 on the blood coagulation system and on interaction with oral anticoagulants].
    Hoffrichter A; Zimmermann R; Walter E; Ehlers W; Andrassy K; Lang PD; Schlierf G; Weber E
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1584-6. PubMed ID: 347788
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of the interractions of cyclamate with phenprocomon (author's transl)].
    Kinawi A; Baumgartl I
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):345-8. PubMed ID: 894206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of bezafibrate on the fibrinolytic enzyme system and the drug interaction with racemic phenprocoumon.
    Zimmermann R; Ehlers W; Walter E; Hoffrichter A; Lang PD; Andrassy K; Schlierf G
    Atherosclerosis; 1978 Apr; 29(4):477-85. PubMed ID: 666891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin and phenprocoumon].
    Deutsch E
    Dtsch Med Wochenschr; 1978 Mar; 103(12):496. PubMed ID: 639670
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lead concentration in blood during treatment with coumarin derivatives].
    Fischer H; Wehran HI
    Z Arztl Fortbild (Jena); 1978 Mar; 72(5):211. PubMed ID: 418581
    [No Abstract]   [Full Text] [Related]  

  • 15. [Increased effect of phenprocoumon (Marcumar) in nephrotic syndrome].
    Heni N; Völger R; Glogner P
    MMW Munch Med Wochenschr; 1980 Feb; 122(5):175-6. PubMed ID: 6767946
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical pharmacology. Is there such a thing as a relevant drug interaction between oxazepam and phenprocoumon?].
    Schneider J; Kamm G
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1577-9. PubMed ID: 347785
    [No Abstract]   [Full Text] [Related]  

  • 17. [Oral anticoagulants and platelet function in hypolipemic therapy using a new clofibrate analog (BM 15.075) (author's transl)].
    Zimmermann R; Hoffrichter A; Walter E; Ehlers W; Andrassy K; Lang PD; Schlierf G; Weber E; Barth P
    Dtsch Med Wochenschr; 1977 Apr; 102(14):509-12. PubMed ID: 852404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Controlled, double blind study of a possible interaction between acemetacin and a concomitant anticoagulant therapy].
    Hess H; Koeppen R
    Arzneimittelforschung; 1980; 30(8A):1421-3. PubMed ID: 7191309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentoxifylline does not interfere with stable coumarin anticoagulant therapy: a clinical study.
    Ingerslev J; Mouritzen C; Stenbjerg S
    Pharmatherapeutica; 1986; 4(9):595-600. PubMed ID: 3763653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of lung tumour colony reduction caused by coumarin anticoagulation.
    Hilgard P; Maat B
    Eur J Cancer (1965); 1979 Feb; 15(2):183-7. PubMed ID: 436894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.